Cargando…
Neurosurgical Clinical Trials for Glioblastoma: Current and Future Directions
The mainstays of glioblastoma treatment, maximal safe resection, radiotherapy preserving neurological function, and temozolomide (TMZ) chemotherapy have not changed for the past 17 years despite significant advances in the understanding of the genetics and molecular biology of glioblastoma. This rev...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221299/ https://www.ncbi.nlm.nih.gov/pubmed/35741672 http://dx.doi.org/10.3390/brainsci12060787 |